Europe
ADL Bionatur Solutions (MAB: ADL), a company specialized in research and development of sustainable health and beauty products, services and industrial fermentation production, announces the expansion of its existing production agreement with Amyris, Inc.
Appointments of Rolf Soderstrom and Dr Jim Esinhart as Non-Executive Directors
Revenue and EBITDA for full year 2019 expected to be ahead of market expectations
NOXXON Pharma N.V., a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment, announces the results of its rights issue for a limited amount of € 521 K.
Sensyne Health plc, the British clinical AI technology company, today welcomes EY Global Services Limited’s report entitled Realising the Value of Healthcare Data.
Turku, Finland, July 19th 2019: Forendo Pharma, a clinical stage drug development company focusing on novel treatments in women’s health, announces that Sunstone Life Science Ventures has made a €5 million investment in Forendo.
Here’s a look at the top clinical trial news from last week, with updates from Neon, GSK, Biohaven, and more.
Novartis Chief Executive Officer Vas Narasimhan is excited about the company’s progress through the first half of 2019 and expects that momentum to continue with a “catalyst-rich” second half of the year.
It was a big week for Alzheimer’s research as researchers from around the world descended on Los Angeles to attend the Alzheimer’s Association International Conference (AAIC) this week. Here’s a look at some of the stories you may have missed.
Acacia’s founder will continue on in an advisory role while ViiV’s departing CSO is eying multiple opportunities.
PRESS RELEASES